Alliqua Inc fka ALQA

[Daniel Son]

From 10Q - Aug 12th

Recent Events

In May of 2012, the composition of our Board of Directors changed with the appointments of Dr. Jerome B. Zeldis and Mr. Kenneth Londoner and the resignations of Dr. Michael Goldberg and Mr. Nachum Stein. Dr. Zeldis, an experienced senior biopharmaceutical executive, is currently the CEO of Celgene Global Health and the Chief Medical Officer of Celgene Corporation. Mr. Londoner is the founder, Chairman, and CEO of BioSig Technologies, Inc., a privately held medical technology company formed in 2009. Mr. Londoner is also the Managing Partner of Endicott Management Partners, LLC, a private investment company focused on medical technology and consumer-related companies.

About Celgene (Trading at $77.86 - Nov. 12, 2012)
http://finance.yahoo.com/q?s=CELG&ql=1

Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of novel therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. For more information, please visit the company's Web site at www.celgene.com

ALQA~